Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Non-contrast CT V: See If CT has a Role in Finding Pulmonary Embolism

Official title: Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)

Run by Massachusetts General Hospital · NCT07527117 · Data updated 2026-11-12

This study tests whether additional low-dose, non-contrast CT scans can help detect pulmonary embolism in patients who are already being evaluated for suspected PE.

More Pulmonary Embolism Acute trials

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment750 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Drugs / interventionsradiation
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedJune 30, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 11, 2026
Trial IDNCT07527117 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 21 years or older undergoing CTPA for suspected acute PE who can consent and meet MMSE criteria (>=18).

Probably not a fit

Participants will not personally benefit from the research procedures.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will add two very low-dose CT image acquisitions during a standard evaluation for suspected PE to see if non-contrast imaging can reveal emboli. Participants will blow into a spirometer to practice breath-holding and will be monitored briefly, totaling about 5 minutes of participation. Medical records may be reviewed for 30 to 90 days after the CT scan. The main risks are radiation exposure and minor spirometer-related discomfort.

Why it matters

Potential benefit: If successful, the approach could improve PE detection with minimal additional radiation.

How similar studies have gone: Prior non-contrast CT research in this area is exploratory and its success is not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients undergoing CTPA for suspected aPE
2. Patients who provide written informed consent to participate
3. Adults patients \>/= 21 years of age
4. Mini Mental State Exam (MMSE) score of 18 or more.

Exclusion Criteria:

1. Patients who decline informed consent
2. Patients with known chronic PE
3. Patients with known interstitial lung diseases
4. Patients who cannot raise their arms above their shoulders (arms can cause serious artifacts)
5. Women of child-bearing potential (\< 55 years) who test positive for pregnancy test
6. Patients \< 21 years of age (to avoid research radiation dose in young patients)
7. Patients with any EMR documented cognitive impairment or diseases such as dementia, recent head injury, psychiatric disorders, or other neurological diseases that impair decision-making.
8. Pregnant subjects
9. Women of child-bearing potential (21-55 years) who refuse to take a urine pregnancy test prior to their CT examination
10. Mini Mental State Exam (MMSE) score of less than 18.

Where it's running

  • Massachusetts General Hospital/Harvard Medical School
    Boston, Massachusetts, United States
    Recruiting
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.